Vaccines Market Research Report: Market size, Industry outlook, Market Forecast, Demand Analysis,Market Share, Market Report 2018-2023
  • 1-614-588-8538 (Ext: 101)
  • US Toll Free

Vaccines Market
Vaccines Market: By Type (Monovalent, Multivalent); By Technology (Conjugate Vaccines, Inactivated and Subunit Vaccines, Others); By Disease Indication (Pneumococcal Disease, DTP, Others); By End User (Paediatrics, Adults) & Region - Forecast(2018 - 2023)
Report Code : HCR 0711
Updated Date: 22 October, 2018  

1.Vaccines Market - Overview
1.1. Definitions and Scope
2.Vaccines Market - Executive summary
2.1. Market Revenue, Market Size and Key Trends by Company
2.2. Key Trends by type of Application
2.3. Key Trends segmented by Geography
3.Vaccines Market 
3.1. Comparative analysis
3.1.1. Product Benchmarking - Top 10 companies
3.1.2. Top 5 Financials Analysis
3.1.3. Market Value split by Top 10 companies
3.1.4. Patent Analysis - Top 10 companies
3.1.5. Pricing Analysis 
4.Vaccines Market – Startup companies Scenario
4.1. Top 10 startup company Analysis by
4.1.1. Investment
4.1.2. Revenue
4.1.3. Market Shares
4.1.4. Market Size and Application Analysis
4.1.5. Venture Capital and Funding Scenario
5.Vaccines Market – Industry Market Entry Scenario
5.1. Regulatory Framework Overview
5.2. New Business and Ease of Doing business index
5.3. Case studies of successful ventures
5.4. Customer Analysis – Top 10 companies
6.Vaccines Market Forces
6.1. Drivers
6.2. Constraints
6.3. Challenges
6.4. Porters five force model
6.4.1. Bargaining power of suppliers
6.4.2. Bargaining powers of customers
6.4.3. Threat of new entrants
6.4.4. Rivalry among existing players
6.4.5. Threat of substitutes 
7.Vaccines Market -Strategic analysis
7.1. Value chain analysis
7.2. Opportunities analysis
7.3. Product life cycle
7.4. Suppliers and distributors Market Share
8.Vaccines Market – By Type (Market Size -$Million / $Billion)
8.1. Market Size and Market Share Analysis 
8.2. Application Revenue and Trend Research
8.3. Product Segment Analysis
8.3.1. Monovalent Vaccines
8.3.2. Multivalent Vaccines
9.Vaccines Market – By Technology (Market Size -$Million / $Billion)
9.1. Conjugate Vaccines
9.2. Inactivated and Subunit Vaccines
9.3. Live Attenuated Vaccines
9.4. Toxoid Vaccines
9.5. Recombinant Vaccines
10.Vaccines Market – By Diseases Indication (Market Size -$Million / $Billion)
10.1. Pneumococcal Disease
10.2. DTP
10.3. Influenza
10.4. Human Papilloma Virus
10.5. Meningococcal Disease
10.6. Polio
10.7. Rotavirus
10.8. Hepatitis
10.9. MMR
10.10. Varicella
10.11. Others
11.Vaccines – By End Use Industry(Market Size -$Million / $Billion)
11.1. Segment type Size and Market Share Analysis 
11.2. Application Revenue and Trends by type of Application
11.3. Application Segment Analysis by Type
11.3.1. Paediatrics
11.3.2. Adults
12.Vaccines - By Geography (Market Size -$Million / $Billion)
12.1.Vaccines Market - North America Segment Research
12.2. North America Market Research (Million / $Billion)
12.2.1. Segment type Size and Market Size Analysis 
12.2.2. Revenue and Trends
12.2.3. Application Revenue and Trends by type of Application
12.2.4. Company Revenue and Product Analysis
12.2.5. North America Product type and Application Market Size
12.2.5.1. U.S.
12.2.5.2. Canada 
12.2.5.3. Mexico 
12.2.5.4. Rest of North America
12.3.Vaccines - South America Segment Research
12.4. South America Market Research (Market Size -$Million / $Billion)
12.4.1. Segment type Size and Market Size Analysis 
12.4.2. Revenue and Trends
12.4.3. Application Revenue and Trends by type of Application
12.4.4. Company Revenue and Product Analysis
12.4.5. South America Product type and Application Market Size
12.4.5.1. Brazil  
12.4.5.2. Venezuela
12.4.5.3. Argentina
12.4.5.4. Ecuador
12.4.5.5. Peru
12.4.5.6. Colombia 
12.4.5.7. Costa Rica
12.4.5.8. Rest of South America
12.5.Vaccines - Europe Segment Research
12.6. Europe Market Research (Market Size -$Million / $Billion)
12.6.1. Segment type Size and Market Size Analysis 
12.6.2. Revenue and Trends
12.6.3. Application Revenue and Trends by type of Application
12.6.4. Company Revenue and Product Analysis
12.6.5. Europe Segment Product type and Application Market Size
12.6.5.1. U.K  
12.6.5.2. Germany 
12.6.5.3. Italy 
12.6.5.4. France
12.6.5.5. Netherlands
12.6.5.6. Belgium
12.6.5.7. Spain
12.6.5.8. Denmark
12.6.5.9. Rest of Europe
12.7.Vaccines – APAC Segment Research
12.8. APAC Market Research (Market Size -$Million / $Billion)
12.8.1. Segment type Size and Market Size Analysis 
12.8.2. Revenue and Trends
12.8.3. Application Revenue and Trends by type of Application
12.8.4. Company Revenue and Product Analysis
12.8.5. APAC Segment – Product type and Application Market Size
12.8.5.1. China 
12.8.5.2. Australia
12.8.5.3. Japan 
12.8.5.4. South Korea
12.8.5.5. India
12.8.5.6. Taiwan
12.8.5.7. Malaysia
13.Vaccines Market - Entropy
13.1. New product launches
13.2. M&A's, collaborations, JVs and partnerships
14.Vaccines Market – Industry / Segment Competition landscape
14.1. Market Share Analysis
14.1.1. Market Share by Country- Top companies
14.1.2. Market Share by Region- Top 10 companies
14.1.3. Market Share by type of Application – Top 10 companies
14.1.4. Market Share by type of Product / Product category- Top 10 companies
14.1.5. Market Share at global level- Top 10 companies
14.1.6. Best Practises for companies
15.Vaccines Market – Key Company List by Country
16.Vaccines Market Company Analysis
16.1. Market Share, Company Revenue, Products, M&A, Developments
16.2. Medimmune, LLC. (A Subsidiary of Astrazeneca)
16.3. Astellas Pharma Inc
16.4. Serum Institute of India
16.5. Emergent Biosolutions, Inc
16.6. Merck & Co., Inc
16.7. Johnson & Johnson
16.8. Sanofi Pasteur
16.9. CSL Limited
16.10. Pfizer, Inc
16.11. Glaxosmithkline, PLC
16.12. Company 11
16.13. Comapny 12
16.14. Company 13 and More
"*Financials would be provided on a best efforts basis for private companies"
17.Vaccines Market -Appendix
17.1. Abbreviations
17.2. Sources
18.Vaccines Market -Methodology
18.1. Research Methodology
18.1.1. Company Expert Interviews
18.1.2. Industry Databases
18.1.3. Associations
18.1.4. Company News
18.1.5. Company Annual Reports
18.1.6. Application Trends
18.1.7. New Products and Product database
18.1.8. Company Transcripts
18.1.9. R&D Trends
18.1.10. Key Opinion Leaders Interviews
18.1.11. Supply and Demand Trends
Please select Licence
Single User Licence:
US $4250
Corporate User Licence:
US $6250
Related Reports
0px;">Scroll